Komori
Occurring Fact6908IRISO ELECTRONICS CO.,LTD.Electrical Equipment and Precision Instruments

Notice Regarding the Formulation of Measures to Prevent Recurrence

Following the third-party committee’s investigation, which found improper payments and other misconduct by an overseas subsidiary, the company resolved measures to prevent recurrence. It also decided on the president’s resignation, the voluntary return of executive compensation, and disciplinary action against the officers and employees involved.

Worth reading
55In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Formulation of measures to prevent recurrence

Subject Entity

IRISO ELECTRONICS CO.,LTD. and the company’s overseas subsidiaries

Target Locations / Products

The company’s overseas subsidiaries, all overseas locations, domestic factories, and the company-wide management and quality control systems

Occurrence30 September 2026 (the date on which the Board of Directors resolved the measures to prevent recurrence and the Representative Director and President resigned)
This disclosure09/30/2026
Cause

Improper payments and other misconduct by an overseas subsidiary. The detailed causes are set out in the analysis of the causes in the third-party committee’s investigation report.

Company response

Investigation structure

Investigation by a third-party committee. The name of the committee chair and the date of its establishment are Not disclosed.

Measures to prevent recurrence

A declaration by top management and senior executives of their commitment to making compliance the top priority; codification of “compliance first”; strengthening governance and reviewing the organizational structure; initiatives to foster and enhance compliance awareness among officers and employees; initiatives to strengthen awareness of foreign public official bribery risks; improvement of the workplace environment; strengthening the management system at headquarters; strengthening mechanisms for collecting risk information; strengthening the internal audit function; and quality-related measures

Directors' and officers' liability

Representative Director and President Suzuki Jin (鈴木仁) resigned effective 30 September 2026. Suzuki Jin (鈴木仁) voluntarily waived 30% of his executive compensation for 6 months. 2 former directors also voluntarily waived part of their executive compensation at the time. Chairman of the Board Shibata Masahisa (柴田雅久), Director and Senior Managing Executive Officer Ikeda Shuichi (池田修一), Director and Managing Executive Officer Ohira Akihiko (大平明彦), Director and Audit and Supervisory Committee Member Miyauchi Toshihiko (宮内敏彦), and all 3 outside directors serving as Audit and Supervisory Committee Members voluntarily waived 10% of their respective executive compensation for 3 months. Strict disciplinary action and other measures were taken against the officers and employees involved, in accordance with the company’s internal regulations.

Related procedures

Type

Investigation by a third-party committee and formulation of measures to prevent recurrence

Outlook

The company will steadily implement the measures to prevent recurrence, strengthen its internal control and corporate governance systems, and work to restore trust and enhance corporate value.

Event that occurred
ItemDetails
Event nameFormulation of measures to prevent recurrence
Date of occurrence30 September 2026 (the date on which the Board of Directors resolved the measures to prevent recurrence and the Representative Director and President resigned)
Subject EntityIRISO ELECTRONICS CO.,LTD. and the company’s overseas subsidiaries
Target Locations / ProductsThe company’s overseas subsidiaries, all overseas locations, domestic factories, and the company-wide management and quality control systems
CauseImproper payments and other misconduct by an overseas subsidiary. The detailed causes are set out in the analysis of the causes in the third-party committee’s investigation report.
Type of litigation or proceedingInvestigation by a third-party committee and formulation of measures to prevent recurrence
Investigation structureInvestigation by a third-party committee. The name of the committee chair and the date of its establishment are Not disclosed.
Measures to prevent recurrenceA declaration by top management and senior executives of their commitment to making compliance the top priority; codification of “compliance first”; strengthening governance and reviewing the organizational structure; initiatives to foster and enhance compliance awareness among officers and employees; initiatives to strengthen awareness of foreign public official bribery risks; improvement of the workplace environment; strengthening the management system at headquarters; strengthening mechanisms for collecting risk information; strengthening the internal audit function; and quality-related measures
Directors' and officers' liabilityRepresentative Director and President Suzuki Jin (鈴木仁) resigned effective 30 September 2026. Suzuki Jin (鈴木仁) voluntarily waived 30% of his executive compensation for 6 months. 2 former directors also voluntarily waived part of their executive compensation at the time. Chairman of the Board Shibata Masahisa (柴田雅久), Director and Senior Managing Executive Officer Ikeda Shuichi (池田修一), Director and Managing Executive Officer Ohira Akihiko (大平明彦), Director and Audit and Supervisory Committee Member Miyauchi Toshihiko (宮内敏彦), and all 3 outside directors serving as Audit and Supervisory Committee Members voluntarily waived 10% of their respective executive compensation for 3 months. Strict disciplinary action and other measures were taken against the officers and employees involved, in accordance with the company’s internal regulations.
OutlookThe company will steadily implement the measures to prevent recurrence, strengthen its internal control and corporate governance systems, and work to restore trust and enhance corporate value.
Items this document does not state (15)
Date recognized / date notice receivedAmount of Impact on Business PerformanceAccounting period in which recognizedImpact on Earnings ForecastCourt or authorityPlaintiffDefendantDate of filing / date of actionClaim amount / surcharge amountAmount of receivables at risk of non-collection or delayed collectionSuspended operationsScheduled resumption dateVoting rights ownership percentage before the changeVoting rights ownership percentage after the changePlanned follow-up disclosure

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The third-party committee’s investigation found improper payments and other misconduct at an overseas subsidiary, and its investigation report included an analysis of the causes and recommendations for preventing recurrence.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Formulation of Measures to Prevent Recurrence | IRISO ELECTRONICS CO.,LTD. (6908) timely disclosure | Komori